Non-treatment extension to study A3051123, aimed at collecting data on cardiovascular safety for all participants in the A3051123 trial for an additional 28 weeks, allowing for a total of 52 weeks of cardiovascular safety data collection.
This study is an extension protocol for study A3051123. No treatment is provided during this study. This study is to monitor for cardiovascular events 28 weeks after completion of A3051123. This study is an extension protocol for study A3051123. No treatment is provided during this study. This study is to monitor for cardiovascular events 28 weeks after completion of A3051123.
All dosing to have taken place per study A3051123
All dosing to have taken place per study A3051123
All dosing to have taken place per study A3051123
All dosing to have taken place per study A3051123
Capital Federal, Buenos Aires, Argentina
Buenos Aires, Buenos Aires F.D., Argentina